Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 3
- Next page
Title | Authors | Year | Journal Sort descending | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
An evaluation of the clinical impacts of 7-day platelets | Ning S, Gabarin N, Li N, Liu Y, Lucier K, Barty R, Acker J, Webert KE, Warkentin TE, Arnold DM, Heddle NM | 2023 | Transfusion | View An evaluation of the clinical impacts of 7-day platelets | Researchers | Clinical research |
Donor iron policy: from research to practice | O'Brien SF | 2016 | Transfusion | View Donor iron policy: from research to practice | Researchers | New or improved product or process |
Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Shehata N, Chassé M, Colas JA, Murphy M, Forster AJ, Malinowski AK, Ducharme R, Fergusson DA, Tinmouth A, Wilson K | 2017 | Transfusion | View Risks and trends of red blood cell transfusion in obstetric patients: a retrospective study of 45,213 deliveries using administrative data | Health care providers | Clinical research |
The Stem Cell Club: a model for unrelated stem cell donor recruitment | Fingrut W, Parmar S, Cuperfain A, Rikhraj K, Charman E, Ptak E, Kahlon M, Graham A, Luong S, Wang YG, Yu J, Arora N, Suppiah R, Li EW, Lee A, Welsh C, Benzaquen M, Thatcher A, Baharmand I, Ladd A, Petraszko T, Allan D, Messner H | 2017 | Transfusion | View The Stem Cell Club: a model for unrelated stem cell donor recruitment | Health care providers | New or improved product or process |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Screening of red blood cells for extracellular vesicle content as a product quality indicator | Acker JP, Almizraq RJ, Millar D, Maurer-Spurej E | 2018 | Transfusion | View Screening of red blood cells for extracellular vesicle content as a product quality indicator | Researchers | New or improved product or process |
Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Shih AW, Liu A, Elsharawi R, Crowther MA, Cook RJ, Heddle NM | 2018 | Transfusion | View Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Researchers | Clinical research |
Evaluating the quality of red blood cell concentrates irradiated before or after cryopreservation | Turner TR, Lautner L, Hill A, Howell A, Skeate R, Acker JP | 2020 | Transfusion | View Evaluating the quality of red blood cell concentrates irradiated before or after cryopreservation | Researchers | Basic research |
Potentially clinically significant anti-Dib identified by monocyte monolayer assay before transfusion | Branch DR, Holton MB, Ison T, Cote J, Dube C, Lau W | 2021 | Transfusion | View Potentially clinically significant anti-Dib identified by monocyte monolayer assay before transfusion | Researchers | Basic research |
The utility of a monocyte monolayer assay in the assessment of intravenous immunoglobulin–associated hemolysis | Tong TN, Blacquiere M, Sakac D, Burke-Murphy E, Yi Q, Callum J, Cserti-Gazdewich C, Parmar N, Shehata N, Pavenski K, Lau W, Lin Y, Lieberman L, Branch DR, Pendergrast J | 2020 | Transfusion | View The utility of a monocyte monolayer assay in the assessment of intravenous immunoglobulin–associated hemolysis | Researchers | New or improved product or process |
Non-invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy | Vardaki MZ, Schulze HG, Serrano K, Blades MW, Devine DV, Turner RFB | 2021 | Transfusion | View Non-invasive monitoring of red blood cells during cold storage using handheld Raman spectroscopy | Researchers | New or improved product or process |
Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada | Sheffield WP, Bhakta V, Howell A, Jenkins C, Serrano K, Johnson N, Lin Y-CJ, Colwill K, Rathod B, Greenberg B, Gingras A-C, Evans DH, Flaumenhaft E, Beckett A, Drews SJ, Devine DV | 2022 | Transfusion | View Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada | Researchers | Basic research |
Alternatives to blood donor deferral of gay, bisexual, and other men who have sex with men: Acceptability of screening the sexual risk behavior of all blood donors | Fisher WA, Kohut T, Woo H, Haw J | 2023 | Transfusion | View Alternatives to blood donor deferral of gay, bisexual, and other men who have sex with men: Acceptability of screening the sexual risk behavior of all blood donors | Blood operators | MSM research |
Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C | 2012 | Transfusion | View Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing | Health care providers | New or improved product or process |
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Christou G, Iyengar A, Shorr R, Tinmouth A, Saidenberg E, Maze D, Tay J, Bredeson C, Allan DS | 2016 | Transfusion | View Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Health care providers | Clinical research |
Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services | O'Brien SF, Scalia V, Goldman M, Fan W, Yi QL, Dines IR, Huang M, Ndao M, Fearon MA | 2012 | Transfusion | View Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services | Blood operators | New or improved product or process |
Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Al-Riyami AZ, Jug R, La Rocca U, Keshavarz H, Landry D, Shehata N, Stanworth SJ, Nahirniak S | 2021 | Transfusion | View Quality of evidence-based guidelines for platelet transfusion and use: A systematic review | Researchers | Benchmarking and standard setting |
How do I think about blood donor eligibility criteria for medical conditions? | Goldman M | 2021 | Transfusion | View How do I think about blood donor eligibility criteria for medical conditions? | Researchers | Benchmarking and standard setting |
Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review | Pavenski K, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation and Evaluation for Transfusion Therapies (ICTMG) Collaborators | 2013 | Transfusion | View Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review | Researchers | Clinical research |
Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients | Zeller MP, Arnold DM, Al Habsi K, Cserti-Gazdewich C, Delage G, Lebrun A, Heddle NM | 2017 | Transfusion | View Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients | Health care providers | Clinical research |
Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage | Schubert P, Culibrk B, Coupland D, Scammell K, Gyongyossy-Issa M, Devine DV | 2012 | Transfusion | View Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage | Researchers | Basic research |
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists | Ghadaki B, Nazi I, Kelton JG, Arnold DM | 2013 | Transfusion | View Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists | Health care providers | Clinical research |
Unraveling the IVIG mystique | Branch DR | 2013 | Transfusion | View Unraveling the IVIG mystique | Researchers | Other |
Improved in vitro quality of stored red blood cells upon oxygen reduction prior to riboflavin/UV light treatment of whole blood | Schubert P, Culibrk B, Chen D, Serrano K, Levin E, Chen Z, Zoescher P, Goodrich RP, Yoshida T, Devine DV | 2019 | Transfusion | View Improved in vitro quality of stored red blood cells upon oxygen reduction prior to riboflavin/UV light treatment of whole blood | Researchers | New or improved product or process |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype | Floch A, Vege S, Berardi P, Hannon J, Ochoa-Garay G, Lomas-Francis C, Westhoff CM | 2022 | Transfusion | View An intron c.149-2632T>A change in RHD is associated with aberrant transcription and very weak D phenotype | Researchers | Clinical research |
Database-driven research and big data analytic approaches in transfusion medicine | Ning S, Li N, Barty R, Arnold D, Heddle NM | 2022 | Transfusion | View Database-driven research and big data analytic approaches in transfusion medicine | Researchers | Clinical research |
Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units | Pasha R, Elmoazzen H, Pineault N | 2017 | Transfusion | View Development and testing of a stepwise thaw and dilute protocol for cryopreserved umbilical cord blood units | Researchers | New or improved product or process |
Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses | Heddle NM, Eikelboom J, Liu Y, Barty R, Cook RJ | 2015 | Transfusion | View Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses | Health care providers | Clinical research |
Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Alabdullatif M, Atreya CD, Ramirez-Arcos S | 2018 | Transfusion | View Antimicrobial peptides: an effective approach to prevent bacterial biofilm formation in platelet concentrates | Researchers | New or improved product or process |
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | MacIsaac J, Siddiqui R, Jamula E, Li N, Baker S, Webert KE, Evanovitch D, Heddle NM, Arnold DM | 2018 | Transfusion | View Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | Researchers | Clinical research |
Evaluation of immunohematology knowledge in hematology trainees | Yan M, Arsenault V, Pendergrast J | 2019 | Transfusion | View Evaluation of immunohematology knowledge in hematology trainees | Health care providers | Other |
Prevalence of Babesia in Canadian blood donors: June–October 2018 | Tonnetti L, O'Brien SF, Grégoire Y, Proctor MC, Drews SJ, Delage G, Fearon MA, Brès V, Linnen JM, Stramer SL | 2019 | Transfusion | View Prevalence of Babesia in Canadian blood donors: June–October 2018 | Researchers | Clinical research |
Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Schubert P, Johnson L, Culibrk B, Chen Z, Tan S, Marks DC, Devine DV | 2021 | Transfusion | View Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Researchers | New or improved product or process |
Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blake JT, McTaggart K, Couture C | 2021 | Transfusion | View Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blood operators | Benchmarking and standard setting |
2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium | Spitalnik SL, Triulzi D, Devine DV, Dzik WH, Eder AF, Gernsheimer T, Josephson CD, Kor DJ, Luban NLC, Roubinian NH, Mondoro T, Welniak LA, Zou S, Glynn S, for the State of the Science in Transfusion Medicine Working G | 2015 | Transfusion | View 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium | Other | Other |
A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing | Acker JP, Hansen AL, Kurach JD, Turner TR, Croteau I, Jenkins C | 2014 | Transfusion | View A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing | Blood operators | Benchmarking and standard setting |
Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop | Gallagher LM, Ganz PR, Yang H, Kessler DA, O'Brien SF, Custer BS, Busch MP, Dodd RY, Stramer SL, Walderhaug MO, Forshee RA, Williams AE, Epstein JS, Anderson SA | 2013 | Transfusion | View Advancing risk assessment for emerging infectious diseases for blood and blood products: proceedings of a public workshop | Blood operators | Other |
Changes in plasma unit distributions to hospitals over a 10-year period | Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH | 2018 | Transfusion | View Changes in plasma unit distributions to hospitals over a 10-year period | Blood operators | Clinical research |
Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates | Greco CA, Zhang JG, Kalab M, Yi Q-L, Ramirez-Arcos SM, Gyongyossy-Issa MIC | 2010 | Transfusion | View Effect of platelet additive solution on bacterial dynamics and their influence on platelet quality in stored platelet concentrates | Researchers | Basic research |
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation | Christou G, Kekre N, Petrcich W, Tokessy M, Neurath D, Giulivi A, Saidenberg E, McDiarmid S, Atkins H, Bence-Bruckler I, Bredeson C, Huebsch L, Sabloff M, Sheppard D, Tay J, Tinmouth A, Allan DS | 2015 | Transfusion | View Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation | Health care providers | Clinical research |
Lessons learned from Trypanosoma cruzi test implementation | Menitove JE, Leach-Bennett J, Sher G | 2012 | Transfusion | View Lessons learned from Trypanosoma cruzi test implementation | Blood operators | Other |
Resolving variable maternal D typing using serology and genotyping in selected prenatal patients | Clarke G, Hannon J, Berardi P, Barr G, Cote J, Fallis R, Alport T, Lane D, Petraszko T, Ochoa G, Goldman M | 2016 | Transfusion | View Resolving variable maternal D typing using serology and genotyping in selected prenatal patients | Health care providers | New or improved product or process |
From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization | Li N, Arnold DM, Down DG, Barty R, Blake J, Chiang F, Courtney T, Waito M, Trifunov R, Heddle NM | 2022 | Transfusion | View From demand forecasting to inventory ordering decisions for red blood cells through integrating machine learning, statistical modeling, and inventory optimization | Researchers | New or improved product or process |
U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysis | Cannon JW, Igra NM, Borge PD, Cap AP, Devine D, Doughty H, Geng Z, Guzman JF, Ness PM, Jenkins DH, Rajbhandary S, Schmulevich D, Stubbs JR, Wiebe DJ, Yazer MH, Spinella PC | 2022 | Transfusion | View U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR-AABB working party prospective analysis | Health care providers | Clinical research |
A flow cytometric method for platelet counting in platelet concentrates | van der Meer PF, Karssing-van Leeuwen W, Kurtz J, Spengler H-P, Blair A, Devine D, Harrison P, Lambrecht B, VandenBroeke T, de Wildt J, de Korte D, on behalf of the Biomedical Excellence for Safer Transfusion C | 2012 | Transfusion | View A flow cytometric method for platelet counting in platelet concentrates | Researchers | New or improved product or process |
Evaluation of CONSORT compliance in TRANSFUSION | Jaffer AM, Wang G, Barty RL, Shih AW | 2015 | Transfusion | View Evaluation of CONSORT compliance in TRANSFUSION | Researchers | Other |
Platelet concentrate functionality assessed by thromboelastography or rotational thromboelastometry | Arbaeen AF, Serrano K, Levin E, Devine DV | 2016 | Transfusion | View Platelet concentrate functionality assessed by thromboelastography or rotational thromboelastometry | Researchers | Basic research |
Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin | Leontyev D, Katsman Y, Ma XZ, Miescher S, Kasermann F, Branch DR | 2012 | Transfusion | View Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin | Researchers | Basic research |